Favus M J, Walling M W, Kimberg D V
J Clin Invest. 1973 Jul;52(7):1680-5. doi: 10.1172/JCI107349.
The administration of glucocorticoids may decrease intestinal calcium absorption in vivo and the active transport of calcium in rat duodenum in vitro. It has been suggested that this apparent "anti-vitamin D-like" effect of steroid hormones may be related to alterations in vitamin D metabolism. In order to test this hypothesis, vitamin D-deficient control and cortisone-treated rats were given an intraperitoneal injection of 5.5 IU of 1,25-dihydroxycholecalciferol (1,25-DHCC), the probable end-organ active vitamin D metabolite in the intestine, and 16 h later studies of duodenal calcium transport were performed in modified Ussing chambers. In the vitamin D-deficient state, cortisone administration was associated with a diminution in J(MS), J(Net), and the flux ratio (J(MS)/J(SM)). While the magnitude of the increases in J(MS) and J(Net) that resulted from 1,25-DHCC treatment were approximately the same in control and cortisone-treated animals, 1,25-DHCC failed to restore these parameters to "normal levels" in the steroid-treated rats. Furthermore, contrary to the results obtained in the saline-treated controls, 1,25-DHCC failed to reduce J(SM) in the duodenum from cortisone-treated rats. The cortisone-related defect in calcium transport was due to alterations in both unidirectional calcium fluxes (decrease in J(MS) and increase in J(SM)), such that the J(Net) and the flux ratio (J(MS)/J(SM)) were only approximately 50% of the levels achieved in vitamin D-deficient control animals repleted with the same dose of 1,25-DHCC. The administration of 1,25-DHCC was accompanied by a marked increase in the serum calcium levels of control rats, but there was no such response in the cortisone-treated group. The results support the concept that under the conditions of these experiments in the rat the apparent antagonism between glucocorticoids and vitamin D may be due to steroid hormone-related alterations in end organ function that are independent of any direct interaction between the hormone and the vitamin and that cannot be reversed by the vitamin.
糖皮质激素的给药可能会降低体内肠道对钙的吸收以及体外大鼠十二指肠中钙的主动转运。有人提出,类固醇激素这种明显的“抗维生素D样”作用可能与维生素D代谢的改变有关。为了验证这一假设,给维生素D缺乏的对照大鼠和可的松处理的大鼠腹腔注射5.5国际单位的1,25 - 二羟胆钙化醇(1,25 - DHCC),这可能是肠道中终末器官活性维生素D代谢产物,16小时后在改良的尤斯灌流小室中进行十二指肠钙转运研究。在维生素D缺乏状态下,给予可的松与J(MS)、J(Net)以及通量比(J(MS)/J(SM))的降低有关。虽然1,25 - DHCC处理导致对照动物和可的松处理动物的J(MS)和J(Net)增加幅度大致相同,但1,25 - DHCC未能使类固醇处理大鼠的这些参数恢复到“正常水平”。此外,与生理盐水处理的对照结果相反,1,25 - DHCC未能降低可的松处理大鼠十二指肠中的J(SM)。可的松相关的钙转运缺陷是由于单向钙通量的改变(J(MS)降低和J(SM)增加),使得J(Net)和通量比(J(MS)/J(SM))仅约为用相同剂量1,25 - DHCC补充的维生素D缺乏对照动物所达到水平的50%。给予1,25 - DHCC伴随着对照大鼠血清钙水平的显著升高,但可的松处理组没有这种反应。结果支持这样的概念,即在大鼠的这些实验条件下,糖皮质激素和维生素D之间明显的拮抗作用可能是由于类固醇激素相关的终末器官功能改变,这种改变独立于激素与维生素之间的任何直接相互作用,并且不能被维生素逆转。